
Join to view full profile
5173 Avenida de la PlataOceanside, CA 92057
Phone+1 310-849-0561
Dr. Audeh is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- M. William Audeh, MD, is a medical oncology based in Oceanside, CA, with expertise in breast cancer, cancer genetics/risk assessment, and molecular oncology. Prior to his medical training, Dr Audeh obtained a Masters Degree in Genetics from the University of Minnesota. He completed his medical education at the University of Iowa Roy J. and Lucille A. Carver College of Medicine in 1982, followed by a residency in Internal Medicine, a year as Chief Medical Resident, and a fellowship in Medical Oncology at Stanford University. Dr. Audeh practiced in the Cedars-Sinai Cancer Center in Los Angeles from 1989 until 2016, specializing in Breast Cancer, during which time he also taught Genomics of Cancer at the UCLA School of Public Health and was Assistant Clinical Professor at UCLA. Dr. Audeh has served as the Chief Medical Officer at Agendia since 2016 and has focused on the genomic profiling of breast cancer. He has contributed numerous publications to the field, with significant citations, especially on PARP inhibitor and olaparib development, as well as a broad range of publications focused on the genomics of breast cancer. He has been involved in multiple clinical trials concerning breast cancer treatment, and has been a founding member of the AACR Cancer Evolution Working Group, which seeks to apply the principles of evolutionary biology to cancer biology and treatment.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Medical Oncology, 1986 - 1989
Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1982 - 1986
University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 1982
University of MinnesotaMS, Genetics, 1977 - 1978
Carleton CollegeBA, Biology, 1973 - 1977
Certifications & Licensure
CA State Medical License 1983 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification OpTime Surgical 2014 Certified Module, Epic Systems Corporation, 2016
- CMS Meaningful Use Stage 1 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2016
- CMS Meaningful Use Stage 1 Certification Sunquest Laboratory, Sunquest Information Systems, Inc., 2016
Clinical Trials
- Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Feb 28
- S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer Start of enrollment: 2013 Sep 12
- A Phase III Trial of Niraparib Versus Physician's Choice in HER2 Negative, Germline BRCA Mutation-positive Breast Cancer Patients Start of enrollment: 2014 Feb 25
Publications & Presentations
PubMed
- 22 citationsA breast cancer gene signature for indolent disease.Leonie J. M. J. Delahaye, CA Drukker, Christa Dreezen, Anke T. Witteveen, Bob Chan
Breast Cancer Research and Treatment. 2017-04-27 - 131 citationsOlaparib monotherapy in patients with advanced relapsed ovarian cancer and a germline BRCA1/2 mutation: a multistudy analysis of response rates and safetyUrsula A. Matulonis, Richard T. Penson, Susan M. Domchek, Bella Kaufman, Ronnie Shapira-Frommer
Annals of Oncology. 2016-06-01 - 238 citationsEfficacy and safety of olaparib monotherapy in germline BRCA1/2 mutation carriers with advanced ovarian cancer and three or more lines of prior therapySusan M. Domchek, Carol Aghajanian, Ronnie Shapira-Frommer, Rita K. Schmutzler, M. William Audeh
Gynecologic Oncology. 2016-02-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









